EU regulator warns on possible MS drugs side effects

[MSUK]

Europe's drug safety regulator said multiple sclerosis treatments known as interferon beta need stronger label warnings because some patients treated with the drugs have suffered side effects affecting the kidney and other organs.

A spokeswoman for the European Medicines Agency said the label change would affect all countries in the European Union............ Read more - http://www.ms-uk.org/drugsresearch